Ricevi le ultime notizie sulle azioni Belite Bio con aggiornamenti su tendenze di mercato, dati finanziari e analisi di Benzinga. Rimani informato sulle performance di BLTE

Ultime notizie per

BELITE BIO INC - ADR

Belite Bio

Belite Bio Inc is a clinical-stage biopharmaceutical drug development company focused on novel therapeutics targeting untreatable eye diseases involving retinal degeneration such as atrophic age-related macular degeneration and autosomal recessive Stargardt disease or STGD1, both of which progressively to permanent blindness, and metabolic diseases such as non-alcoholic fatty liver disease, or NAFLD, nonalcoholic steatohepatitis, or NASH, type 2 diabetes, or T2D, and gout.

Belite Bio, Inc - American Depositary Shares

Belite Bio Inc

Health Care

Press Releases

Belite Bio Announces FDA Granting of Breakthrough Therapy Designation for Tinlarebant for the Treatment of Stargardt Disease

Belite Bio Announces Completion of Enrollment in the Pivotal Global Phase 3 PHOENIX Trial Evaluating Oral Tinlarebant in Geographic Atrophy

News

Belite Bio to Participate in the BTIG Virtual Biotechnology Conference

Belite Bio to Host Webcast on August 11, 2025, to Discuss Second Quarter 2025 Financial Results

Belite Bio to Participate in the H.C. Wainwright Annual Ophthalmology Virtual Conference

Belite Bio Announces Registered Direct Offering of $15 Million

Earnings

Belite Bio Reports Second Quarter 2025 Financial Results and Provides a Corporate Update

Belite Bio to Participate in Three Upcoming Investor Conferences

Financing

Belite Bio Announces Up to $275 Million Upsized Private Placement Financing by Leading Healthcare Investors

Belite Bio Announces Completion of DRAGON, a 2-Year, Phase 3 Trial of Oral Tinlarebant in the Treatment of Stargardt Disease

BLTE

Amylyx Pharmaceuticals, Inc. - Common Stock

Amylyx Pharmaceuticals

Amneal Pharmaceuticals, Inc. - Class A Common Stock

Amneal Pharmaceuticals

ANI Pharmaceuticals

Avadel Pharmaceuticals plc - Ordinary Share

Avadel Pharmaceuticals

Axsome Therapeutics

BGM Group

Crinetics Pharmaceuticals, Inc. - Common Stock

Crinetics Pharmaceuticals

Edgewise Therapeutics, Inc. - Common Stock

Edgewise Therapeutics

Structure Therapeutics Inc. - American Depositary Shares

Structure Therapeutics

HUTCHMED (China) Limited - American Depositary Shares

HUTCHMED (China)

Harmony Biosciences Holdings, Inc. - Common Stock

Harmony Biosciences Hldgs

Harrow

Indivior

Jazz Pharmaceuticals plc - Ordinary Shares

Jazz Pharmaceuticals

Ligand Pharmaceuticals Incorporated - Common Stock

Ligand Pharmaceuticals

Liquidia

Ocular Therapeutix

Organon

Phibro Animal Health Corporation - Class A Common Stock

Phibro Animal Health

Prestige Consumer Healthcare Inc. Common Stock

Prestige Consumer

Pharvaris

Regencell Bioscience Holdings Limited - Ordinary Shares

Regencell Bioscience

Supernus Pharmaceuticals, Inc. - Common Stock

Supernus Pharmaceuticals

Tarsus Pharmaceuticals, Inc. - Common Stock

Comments

Belite Bio Notizie sulle azioni

Notizie

Ultime notizie per

Le persone guardano anche

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO